All terms in GO

Label Id Description
obsolete phenylboronic acid monooxygenase activity GO_0034950 [OBSOLETE. Catalysis of the reaction: phenylboronic acid + O2 + 2 H+ + 2 e- = phenol + B(OH)3.]
obsolete positive regulation of vitamin D 24-hydroxylase activity GO_0010980 [OBSOLETE. Any process that increases the rate, frequency or extent of vitamin D 24-hydroxylase activity. Vitamin D 24-hydroxylase activity catalyzes the hydroxylation of C-24 of any form of vitamin D.]
soluble molecule recognition GO_0009995 [The recognition of soluble molecules in the environment.]
detection of chemical stimulus GO_0009593 [The series of events in which a chemical stimulus is received by a cell and converted into a molecular signal.]
obsolete o-hydroxylaminobenzoate mutase activity GO_0034951 [OBSOLETE. Catalysis of the reaction: o-hydroxylaminobenzoate = 3-hydroxyanthranilate.]
negative regulation of retinal cone cell fate specification GO_0009998 [Any process that restricts, stops or prevents a cell from specifying into a retinal cone cell.]
negative regulation of retinal cone cell fate commitment GO_0060226 [Any process that increases the process in which a cell becomes committed to a retinal cone cell fate. Retinal cone cell fate commitment is the process in which the developmental fate of a cell becomes restricted such that it will develop into a retinal cone cell.]
regulation of retinal cone cell fate specification GO_0042673 [Any process that mediates the specification of a cell into a retinal cone cell.]
negative regulation of auditory receptor cell fate specification GO_0009999 [Any process that restricts, stops or prevents a cell from specifying into an auditory hair cell.]
regulation of inner ear auditory receptor cell fate specification GO_0042669 [Any process that mediates the specification of a cell into an auditory hair cell.]
negative regulation of inner ear auditory receptor cell differentiation GO_0045608 [Any process that stops, prevents, or reduces the frequency, rate or extent of auditory hair cell differentiation.]
inositol catabolic process GO_0019310 [The chemical reactions and pathways resulting in the breakdown of inositol, 1,2,3,4,5,6-cyclohexanehexol, a growth factor for animals and microorganisms.]
inositol metabolic process GO_0006020 [The chemical reactions and pathways involving inositol, 1,2,3,4,5,6-cyclohexanehexol, a growth factor for animals and microorganisms.]
obsolete sorbose metabolic process GO_0019311 [OBSOLETE. The chemical reactions and pathways involving sorbose, the ketohexose xylo-2-hexulose. Sorbose is produced commercially by fermentation and is used as an intermediate in the manufacture of ascorbic acid.]
obsolete L-sorbose metabolic process GO_0019312 [OBSOLETE. The chemical reactions and pathways involving sorbose, the L-enantiomer of the ketohexose xylo-2-hexulose. L-sorbose is formed by bacterial oxidation of sorbitol.]
obsolete allose metabolic process GO_0019313 [OBSOLETE. The chemical reactions and pathways involving allose, allo-hexose, an aldohexose similar to glucose, differing only in the configuration of the hydroxyl group of C-3.]
obsolete D-allose metabolic process GO_0019314 [OBSOLETE. The chemical reactions and pathways involving D-allose, the D-enantiomer of allo-hexose, an aldohexose similar to glucose.]
D-allose biosynthetic process GO_0019315 [The chemical reactions and pathways resulting in the formation of D-allose, the D-enantiomer of allo-hexose, an aldohexose similar to glucose.]
negative regulation of low-density lipoprotein particle clearance GO_0010989 [Any process that decreases the rate, frequency or extent of low-density lipoprotein particle clearance. Low-density lipoprotein particle clearance is the process in which a low-density lipoprotein particle is removed from the blood via receptor-mediated endocytosis and its constituent parts degraded.]
negative regulation of lipoprotein particle clearance GO_0010985 [Any process that decreases the rate, frequency, or extent of lipoprotein particle clearance. Lipoprotein particle clearance is the process in which a lipoprotein particle is removed from the blood via receptor-mediated endocytosis and its constituent parts degraded.]